Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

Journal: Nutrients
Published Date:

Abstract

Hypertension is a major cardiovascular risk factor that is responsible for a heavy burden of morbidity and mortality worldwide. A critical aspect of cardiovascular risk estimation in hypertensive patients depends on the assessment of hypertension-mediated organ damage (HMOD), namely the generalized structural and functional changes in major organs induced by persistently elevated blood pressure values. The vasculature of the eye shares several common structural, functional, and embryological features with that of the heart, brain, and kidney. Since retinal microcirculation offers the unique advantage of being directly accessible to non-invasive and relatively simple investigation tools, there has been considerable interest in the development and modernization of techniques that allow the assessment of the retinal vessels' structural and functional features in health and disease. With the advent of artificial intelligence and the application of sophisticated physics technologies to human sciences, consistent steps forward have been made in the study of the ocular fundus as a privileged site for diagnostic and prognostic assessment of diverse disease conditions. In this narrative review, we will recapitulate the main ocular imaging techniques that are currently relevant from a clinical and/or research standpoint, with reference to their pathophysiological basis and their possible diagnostic and prognostic relevance. A possible non pharmacological approach to prevent the onset and progression of retinopathy in the presence of hypertension and related cardiovascular risk factors and diseases will also be discussed.

Authors

  • Rita Del Pinto
    Internal Medicine and Nephrology Unit, Department of Clinical Medicine, Public Health, Life and Environmental Sciences, San Salvatore Hospital, University of L'Aquila, 67100 L'Aquila, AQ, Italy.
  • Giuseppe Mulè
    Unit of Nephrology and Hypertension, Dipartimento PROMISE (Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties), Università di Palermo, 90133 Palermo, PA, Italy.
  • Maria Vadalà
    Biomedicine, Neuroscience and Advanced Diagnostic Department, IEMEST, Euro-Mediterranean Institute of Science and Technology, University of Palermo, 90133 Palermo, PA, Italy.
  • Caterina Carollo
    Unit of Nephrology and Hypertension, Dipartimento PROMISE (Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties), Università di Palermo, 90133 Palermo, PA, Italy.
  • Santina Cottone
    Unit of Nephrology and Hypertension, Dipartimento PROMISE (Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties), Università di Palermo, 90133 Palermo, PA, Italy.
  • Claudia Agabiti Rosei
    Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, 25121 Brescia, BS, Italy.
  • Carolina De Ciuceis
    Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, 25121 Brescia, BS, Italy.
  • Damiano Rizzoni
    Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, 25121 Brescia, BS, Italy.
  • Claudio Ferri
    Internal Medicine and Nephrology Unit, Department of Clinical Medicine, Public Health, Life and Environmental Sciences, San Salvatore Hospital, University of L'Aquila, 67100 L'Aquila, AQ, Italy.
  • Maria Lorenza Muiesan
    Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, 25121 Brescia, BS, Italy.